Cargando…

Role of Intravenous Ascorbic Acid in the Management of Anemia in Hemodialysis Patients

INTRODUCTION: Patients with end-stage kidney disease (ESKD) suffer from functional iron deficiency where despite the presence of sufficient iron stores in the body, adequate iron is unavailable for heme synthesis. This study hypothesis was that in patients undergoing hemodialysis (HD), administratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Shinnawy, Howayda, Khedr, Abdel Rahman, Alghitany, Ahmad, Ramzy, Marina, Baki, Aber Halim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330662/ https://www.ncbi.nlm.nih.gov/pubmed/34376935 http://dx.doi.org/10.4103/ijn.IJN_356_19

Ejemplares similares

The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
por: Kang, Dae Woong, et al.
Publicado: (2012)

Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients
por: Jalalzadeh, M., et al.
Publicado: (2012)

Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial
por: Sedighi, Omid, et al.
Publicado: (2013)

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
por: Wagner, Samuel C, et al.
Publicado: (2014)

Administration of Intravenous Ascorbic Acid—Practical Considerations for Clinicians
por: Walker, Scott E., et al.
Publicado: (2019)

Are there any further modalities for prediction of subclinical volume overload in advanced stages of chronic kidney disease?
por: Baki, Aber Halim, et al.
Publicado: (2021)

Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients
por: Prasad, Bhanu, et al.
Publicado: (2020)

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
por: Ichim, Thomas E, et al.
Publicado: (2011)

Hemodialysis patients’ preferences for the management of anemia
por: Hauber, Brett, et al.
Publicado: (2017)

Role of alpha-lipoic acid in the management of anemia in patients with chronic renal failure undergoing hemodialysis
por: El-Nakib, Gehad A, et al.
Publicado: (2013)

A Case of Factitious Hyperglycemia in a Patient on Intravenous Ascorbic Acid
por: Sharma, Eliza, et al.
Publicado: (2018)

Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer
por: Bazzan, Anthony J., et al.
Publicado: (2018)

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
por: Fowler, Alpha A, et al.
Publicado: (2014)

Intravenous Ascorbic Acid and Lung Function in Severely Ill COVID-19 Patients
por: Sokary, Sara, et al.
Publicado: (2022)

Anemia management: development of a rapidaccess anemia and intravenous iron service
por: Radia, Deepti, et al.
Publicado: (2013)

Reduced Plasma Ascorbate and Increased Proportion of Dehydroascorbic Acid Levels in Patients Undergoing Hemodialysis
por: Doshida, Yuta, et al.
Publicado: (2021)

Membrane Permeabilities of Ascorbic Acid and Ascorbate
por: Hannesschlaeger, Christof, et al.
Publicado: (2018)

Cytotoxic and Antioxidative Effects of Geranium Oil and Ascorbic Acid Coloaded in Niosomes against MCF-7 Breast Cancer Cells
por: Fahmy, Sherif Ashraf, et al.
Publicado: (2023)

Successful creation of an anemia management algorithm for hemodialysis patients
por: Hara, Kazuhiro, et al.
Publicado: (2015)

Modulation of Cytokines in Cancer Patients by Intravenous Ascorbate Therapy
por: Mikirova, Nina, et al.
Publicado: (2016)

Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
por: Nauman, Gina, et al.
Publicado: (2018)

PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells
por: Fahmy, Sherif Ashraf, et al.
Publicado: (2022)

On the relevance of outpatient intravenous iron therapy for anemia management
por: Muñoz, Manuel
Publicado: (2011)

Pharmacokinetics of intravenous administered two different high doses of ascorbic acid in healthy beagle dogs
por: Lim, Seula, et al.
Publicado: (2019)

Trends in anemia management in US hemodialysis patients 2004–2010
por: Miskulin, Dana C, et al.
Publicado: (2013)

Impact of Water Treatment on Anemia in Hemodialysis Patients
por: Hassan, Mohamed S., et al.
Publicado: (2023)

Stability of aqueous solutions of ascorbate for basic research and for intravenous administration
por: Wagner, Brett A., et al.
Publicado: (2023)

Effects of novel anemia nurse manager program on hemodialysis: a retrospective study from Qatar
por: Hamad, Abdullah, et al.
Publicado: (2021)

Observations of Ascorbic Acid. Part XI. Therapeutic Effect of Ascorbic Acid in Tuberculosis
por: Babbar, Inder Jit
Publicado: (1948)

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
por: Monti, Daniel A., et al.
Publicado: (2012)

Alleviation of ascorbic acid-induced gastric high acidity by calcium ascorbate in vitro and in vivo
por: Lee, Joon-Kyung, et al.
Publicado: (2018)

Hydrocortisone, Ascorbic Acid and Thiamine (HAT Therapy) for the Treatment of Sepsis. Focus on Ascorbic Acid
por: Marik, Paul E.
Publicado: (2018)

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece
por: Fragoulakis, Vassilis, et al.
Publicado: (2012)

ON THE INACTIVATION OF ASCORBIC ACID OXIDASE
por: Powers, Wendell H., et al.
Publicado: (1944)

The Precursor of Ascorbic Acid in Vitro
por: Babbar, Inder Jit
Publicado: (1949)

Ascorbic acid in septic shock
por: Khalili, Hossein
Publicado: (2016)

Ascorbic Acid and the Premature Infant
por: Chahin, Nayef, et al.
Publicado: (2022)

A randomized feasibility study of the effect of ascorbic acid on post-angioplasty restenosis of hemodialysis vascular access (NCT03524846)
por: Yang, Chung-Wei, et al.
Publicado: (2019)

Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients
por: Beiraghdar, Fatemeh, et al.
Publicado: (2015)

Administration of pentoxifylline to improve anemia of hemodialysis patients
por: Shahbazian, Heshmatolah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5tmb9ms8vlovsd9hgdvd1auenf